Here’s Why Armata Pharmaceuticals Inc. (ARMP) is a High Growth Micro-Cap Stock to Buy?

Armata Pharmaceuticals Inc. (NYSE:ARMP) is one of the high-growth micro-cap stocks to buy now. On May 7, Armata Pharmaceuticals Inc. (NYSE:ARMP) achieved a significant milestone when the U.S Food and Drug Administration granted Fast Track Designation to AP-SA02.

Here’s Why Armata Pharmaceuticals Inc. (ARMP) is a High Growth Micro-Cap Stock to Buy?

Photo by Myriam Zilles on Unsplash

AP-SA02 is the company’s intravenously administered multi-phage product for the treatment of complicated bacteremia caused by Staphylococcus aureus. The designation underscores the potential of the candidate drug to improve upon current standards and care of treatment for complicated Staphylococcus aureus bacteremia SAB.

The designation is designed to facilitate and expedite the review of investigational therapies for serious conditions with tremendous potential. It also paves the way for the rolling of a Biologic License Application and eligibility for Accelerated Approval and Priority Review.

Following the designation, Armata Pharmaceutical is poised to pursue a Phase 3 superiority study set for the second half of the year. The company has already entered into a secured credit agreement with Innoviva Strategic Opportunities for a $25 million loan. Proceeds from the transaction will be used to finance the development of AP-SA02.

Armata Pharmaceuticals Inc. (NYSE:ARMP) is a clinical-stage biotechnology company developing precisely targeted, pathogen-specific bacteriophage (phage) therapeutics to treat antibiotic-resistant and difficult-to-treat bacterial infections. Their mission is to combat the global antibiotic resistance crisis while preserving the healthy human microbiome.

While we acknowledge the risk and potential of ARMP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ARMP and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Billionaire Ken Fisher’s Top 12 High-Growth Stock Picks and 12 Best Tech Stocks to Invest In on the Dip.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1